Molina's Profit Slides 52% as Medicaid Managed Care Awaits a 2027 Rate Reset

Molina Healthcare's third-quarter numbers tell a familiar story for Medicaid-focused insurers this earnings season: profits down sharply, revenue softer, but management pointing to 2027 as the year the math finally works again.

The company reported $38 million in net income for the quarter, down from $79 million a year earlier. Through nine months, profit stands at $112 million, a steep drop from $632 million over the same period in 2025. Revenue for the quarter came in at $11.1 billion, versus $11.5 billion last year. Year-to-date revenue is $32.8 billion, down from $34.1 billion.

Those are not small declines. Nine-month profit is off by roughly 82% year over year. That kind of compression usually triggers alarm bells. Instead, CEO Joseph Zubretsky used Thursday's call to lay out a case for why the worst of the Medicaid rate cycle may be behind the industry, not ahead of it.

The thesis rests on three legs. States are set to fold more current data into their Medicaid rate calculations. Work requirements, which take effect nationwide on Jan. 1, could shift the remaining enrolled population toward higher acuity, and that shift should eventually show up in actuarially sound rates. CFO Mark Keim noted that some states have already shown willingness to revisit rates mid-year rather than waiting for the standard annual cycle.

Zubretsky is modeling a medical cost trend of 5.5% to 6% for Medicaid next year, with a flat medical loss ratio. "Using the upper end of our trend range, we take the early view that rates should, at a minimum, capture trend for 2027," he said. That is a notably specific commitment from a management team that has spent much of the past two years explaining margin misses tied to rate lag.

Disenrollment Timing and the MLR Picture

The quarter's medical loss ratio landed at 92.9% overall, with the Medicaid-specific figure at 93%. Keim characterized both as in line with expectations, crediting rate adjustments for largely offsetting medical cost trend pressure during the quarter. That is a meaningfully better outcome than a scenario where trend simply outruns reimbursement, which has been the industry's dominant narrative since 2024.

Work requirements are the wildcard nobody can fully price yet. Zubretsky said Molina is coordinating closely with state partners on implementation, and expects timing to vary significantly by state. Mechanisms like ex parte reviews, flexible hardship exemptions and self-attestation options mean a meaningful share of disenrollments that might otherwise hit in 2027 could instead be pushed into 2028. "We continue to expect membership reductions to emerge gradually and to produce a minor acuity impact," Zubretsky said. Total membership currently sits at 4.9 million, with 4.4 million of that in Medicaid plans.

The broader policy backdrop makes this delayed-impact framing worth scrutinizing rather than simply accepting at face value. A Commonwealth Fund survey of 9,360 adults, conducted between May and July, found the uninsured rate climbed to 11.2% in 2026, up from 8.9%. Lead author Sara Collins attributed the jump to the expiration of enhanced ACA premium tax credits and the end of a post-COVID policy that had made it easier to retain Medicaid coverage, both ahead of the work requirements rollout. The Congressional Budget Office projects these combined policy changes will push the uninsured population up by 11 million by 2036, reaching roughly 37 million.

That is the structural tension sitting underneath Molina's optimism. Gradual disenrollment delays margin pressure for insurers in the near term, but it does not change the destination. Half of adults surveyed by Commonwealth Fund said they had skipped necessary care due to cost in the past year, up from 46% in 2022. Three-quarters of respondents, including 93% of Democrats and 45% of Republicans, said they believe the federal government should ensure universal coverage. Collins called the gap between policy direction and public expectation "directionally opposite," a dynamic that could eventually resurface as political risk for the managed care model Molina depends on.

Molina's own Affordable Care Act exposure is already shrinking. The company has flagged plans for further marketplace exits as that segment underperforms, a retreat that narrows its business to a more concentrated Medicaid and Medicare bet at exactly the moment Medicaid enrollment dynamics are shifting.

The Bottom Line

Molina reaffirmed full-year guidance of $5.25 in earnings per share on roughly $42 billion in revenue, a signal that management believes the quarter's weakness is transitional rather than structural. Keim's framing, that current trends "position us well for profitable growth in 2027," hinges on two assumptions investors should stress-test individually: that states actually follow through on rate adjustments calibrated to post-work-requirement acuity, and that disenrollment delays genuinely push volume (not just cost) into 2028 rather than simply deferring a reckoning.

Both assumptions are plausible. Neither is guaranteed. State budgets remain under their own pressure, and the political appetite for generous Medicaid rate-setting is not uniform across 50 state legislatures. Meanwhile, the Commonwealth Fund data suggests the human cost of this transition, rising uninsurance, deferred care, mounting affordability complaints, is accumulating in parallel with the industry's financial recovery narrative. For a stock trading on the promise of 2027 rate alignment, that gap between corporate guidance and population-level outcomes is the risk worth watching most closely over the next two quarters.